Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ.
J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15.
Similar articles
Natural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomy.
Hernandez DJ, Nielsen ME, Han M, Trock BJ, Partin AW, Walsh PC, Epstein JI.
Urology. 2008 Jul;72(1):172-6. doi: 10.1016/j.urology.2007.10.055. Epub 2008 Mar 4.
Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC.
J Urol. 2001 Aug;166(2):416-9.
Causes of death after radical prostatectomy at a large tertiary center.
Eifler JB, Humphreys EB, Agro M, Partin AW, Trock BJ, Han M.
J Urol. 2012 Sep;188(3):798-801. doi: 10.1016/j.juro.2012.04.109. Epub 2012 Jul 20.
Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease.
Han M, Walsh PC, Partin AW, Rodriguez R.
J Urol. 2000 Jul;164(1):89-92.
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
J Urol. 2003 Feb;169(2):517-23.
The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
Jeong BC, Chalfin HJ, Lee SB, Feng Z, Epstein JI, Trock BJ, Partin AW, Humphreys E, Walsh PC, Han M.
Eur Urol. 2015 Feb;67(2):342-6. doi: 10.1016/j.eururo.2014.06.015. Epub 2014 Jun 23.
Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications.
Han M, Pound CR, Potter SR, Partin AW, Epstein JI, Walsh PC.
J Urol. 2001 Mar;165(3):864-6.
Prostate specific antigen versus prostate specific antigen density as a prognosticator of pathological characteristics and biochemical recurrence following radical prostatectomy.
Magheli A, Rais-Bahrami S, Trock BJ, Humphreys EB, Partin AW, Han M, Gonzalgo ML.
J Urol. 2008 May;179(5):1780-4; discussion 1784. doi: 10.1016/j.juro.2008.01.032. Epub 2008 Mar 17.
An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series.
Han M, Partin AW, Chan DY, Walsh PC.
J Urol. 2004 Jan;171(1):23-6.
Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Cadeddu JA, Partin AW, Epstein JI, Walsh PC.
Urology. 1997 Aug;50(2):251-5.
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML, Bergstralh EJ, Partin AW, Walsh PC, Kattan MW, Scardino PT, Montie JE, Pearson JD, Slezak JM, Zincke H.
J Urol. 2000 Nov;164(5):1591-5.
Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.
Khan MA, Han M, Partin AW, Epstein JI, Walsh PC.
Urology. 2003 Jul;62(1):86-91; discussion 91-2.
Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center.
Nielsen ME, Han M, Mangold L, Humphreys E, Walsh PC, Partin AW, Freedland SJ.
J Urol. 2006 Aug;176(2):515-9.
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW.
Urology. 2007 Jun;69(6):1095-101.
Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.
Urology. 2008 Dec;72(6):1246-51. doi: 10.1016/j.urology.2008.01.052. Epub 2008 Apr 2.
Radical prostatectomy for high grade disease: a reevaluation 1994.
Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI.
J Urol. 1994 Jun;151(6):1583-6.
Serum acid phosphatase level and biochemical recurrence following radical prostatectomy for men with clinically localized prostate cancer.
Han M, Piantadosi S, Zahurak ML, Sokoll LJ, Chan DW, Epstein JI, Walsh PC, Partin AW.
Urology. 2001 Apr;57(4):707-11.
Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years.
Walsh PC, Partin AW, Epstein JI.
J Urol. 1994 Nov;152(5 Pt 2):1831-6.
Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy.
Chan TY, Partin AW, Walsh PC, Epstein JI.
Urology. 2000 Nov 1;56(5):823-7.
Filters: Manage Filters